Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Table of Contents

October 1, 1996; Volume 157,Issue 7

CUTTING EDGE

  • You have accessRestricted access
    Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease.
    R A Seder, B L Kelsall and D Jankovic
    J Immunol October 1, 1996, 157 (7) 2745-2748;
  • You have accessRestricted access
    IL-4 induces Fas resistance in B cells.
    L C Foote, R G Howard, A Marshak-Rothstein and T L Rothstein
    J Immunol October 1, 1996, 157 (7) 2749-2753;
  • You have accessRestricted access
    Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist.
    J M Glynn, D L McElligott and D E Mosier
    J Immunol October 1, 1996, 157 (7) 2754-2758;
  • You have accessRestricted access
    Molecular cloning of TER1, a chemokine receptor-like gene expressed by lymphoid tissues.
    M Napolitano, A Zingoni, G Bernardini, G Spinetti, A Nista, C T Storlazzi, M Rocchi and A Santoni
    J Immunol October 1, 1996, 157 (7) 2759-2763;
  • You have accessRestricted access
    CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L.
    S Shinde, Y Wu, Y Guo, Q Niu, J Xu, I S Grewal, R Flavell and Y Liu
    J Immunol October 1, 1996, 157 (7) 2764-2768;

ARTICLES

  • You have accessRestricted access
    A role for phosphatidylinositol 3-kinase in generating T cell help for B cell growth and differentiation.
    K M Aagaard-Tillery and D F Jelinek
    J Immunol October 1, 1996, 157 (7) 2769-2778;
  • You have accessRestricted access
    B cell responses to a peptide epitope. I. The cellular basis for restricted recognition.
    A Agarwal, S Sarkar, C Nazabal, G Balasundaram and K V Rao
    J Immunol October 1, 1996, 157 (7) 2779-2788;
  • You have accessRestricted access
    Expression and presentation of endogenous mouse mammary tumor virus superantigens by thymic and splenic dendritic cells and B cells.
    C Ardavín, G Waanders, I Ferrero, F Anjuère, H Acha-Orbea and H R MacDonald
    J Immunol October 1, 1996, 157 (7) 2789-2794;
  • You have accessRestricted access
    CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.
    E M Beckman, A Melián, S M Behar, P A Sieling, D Chatterjee, S T Furlong, R Matsumoto, J P Rosat, R L Modlin and S A Porcelli
    J Immunol October 1, 1996, 157 (7) 2795-2803;
  • You have accessRestricted access
    Clonotypic differences in signaling from CD94 (kp43) on NK cells lead to divergent cellular responses.
    K M Brumbaugh, J J Pérez-Villar, C J Dick, R A Schoon, M López-Botet and P J Leibson
    J Immunol October 1, 1996, 157 (7) 2804-2812;
  • You have accessRestricted access
    Distribution of IL-15 receptor alpha-chains on human peripheral blood mononuclear cells and effect of immunosuppressive drugs on receptor expression.
    D W Chae, Y Nosaka, T B Strom and W Maslinski
    J Immunol October 1, 1996, 157 (7) 2813-2819;
  • You have accessRestricted access
    Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Y L Colson, H Li, S S Boggs, K D Patrene, P C Johnson and S T Ildstad
    J Immunol October 1, 1996, 157 (7) 2820-2829;
  • You have accessRestricted access
    Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    D J Cua, R L Coffman and S A Stohlman
    J Immunol October 1, 1996, 157 (7) 2830-2836;
  • You have accessRestricted access
    Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition.
    M D Goldstein and T H Watts
    J Immunol October 1, 1996, 157 (7) 2837-2843;
  • You have accessRestricted access
    Activation of the Ras signaling pathway by the CD40 receptor.
    E Gulbins, B Brenner, K Schlottmann, U Koppenhoefer, O Linderkamp, K M Coggeshall and F Lang
    J Immunol October 1, 1996, 157 (7) 2844-2850;
  • You have accessRestricted access
    IL-12 p40 messenger RNA expression in target organs during acute graft-versus-host disease. Possible involvement of IFN-gamma.
    K Kichian, F P Nestel, D Kim, P Ponka and W S Lapp
    J Immunol October 1, 1996, 157 (7) 2851-2856;
  • You have accessRestricted access
    Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    P A Lando, C Olsson, T Kalland, D Newton, M Kotb and M Dohlsten
    J Immunol October 1, 1996, 157 (7) 2857-2863;
  • You have accessRestricted access
    Expression of trKB neurotrophin receptor during T cell development. Role of brain derived neurotrophic factor in immature thymocyte survival.
    M Maroder, D Bellavia, D Meco, M Napolitano, A Stigliano, E Alesse, A Vacca, G Giannini, L Frati, A Gulino and I Screpanti
    J Immunol October 1, 1996, 157 (7) 2864-2872;
  • You have accessRestricted access
    Extrathymic origin of human gamma delta T cells during fetal development.
    L D McVay and S R Carding
    J Immunol October 1, 1996, 157 (7) 2873-2882;
  • You have accessRestricted access
    Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope.
    J A Mikszta and B S Kim
    J Immunol October 1, 1996, 157 (7) 2883-2890;
  • You have accessRestricted access
    Differential effects of a monoclonal antibody to cis-urocanic acid on the suppression of delayed and contact hypersensitivity following ultraviolet irradiation.
    A M Moodycliffe, C D Bucana, M L Kripke, M Norval and S E Ullrich
    J Immunol October 1, 1996, 157 (7) 2891-2899;
  • You have accessRestricted access
    Requirements for induction of vitamin D-mediated gene regulation in normal human B lymphocytes.
    J W Morgan, D M Morgan, S R Lasky, D Ford, N Kouttab and A L Maizel
    J Immunol October 1, 1996, 157 (7) 2900-2908;
  • You have accessRestricted access
    Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells.
    Y Oshimi, S Oda, Y Honda, S Nagata and S Miyazaki
    J Immunol October 1, 1996, 157 (7) 2909-2915;
  • You have accessRestricted access
    Role of alpha 5 beta 1 integrin in TGF-beta 1-costimulated CD8+ T cell growth and apoptosis.
    S Rich, N Van Nood and H M Lee
    J Immunol October 1, 1996, 157 (7) 2916-2923;
  • You have accessRestricted access
    B7 costimulation and autoantigen specificity enable B cells to activate autoreactive T cells.
    R Roth, T Nakamura and M J Mamula
    J Immunol October 1, 1996, 157 (7) 2924-2931;
  • You have accessRestricted access
    Activation of human T cell lymphotropic virus type I-infected T cells is independent of B7 costimulation.
    C Scholz, G J Freeman, E A Greenfield, D A Hafler and P Höllsberg
    J Immunol October 1, 1996, 157 (7) 2932-2938;
  • You have accessRestricted access
    Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY.
    J Szöllósi, V Horejsí, L Bene, P Angelisová and S Damjanovich
    J Immunol October 1, 1996, 157 (7) 2939-2946;
  • You have accessRestricted access
    Quantitative analysis of the influenza virus-specific CD4+ T cell memory in the absence of B cells and Ig.
    D J Topham, R A Tripp, A M Hamilton-Easton, S R Sarawar and P C Doherty
    J Immunol October 1, 1996, 157 (7) 2947-2952;
  • You have accessRestricted access
    The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta.
    O P Veiby, F W Jacobsen, L Cui, S D Lyman and S E Jacobsen
    J Immunol October 1, 1996, 157 (7) 2953-2960;
  • You have accessRestricted access
    CD95-dependent bystander lysis caused by CD4+ T helper 1 effectors.
    R Wang, A M Rogers, T L Ratliff and J H Russell
    J Immunol October 1, 1996, 157 (7) 2961-2968;
  • You have accessRestricted access
    Ig light chains are secreted predominantly as monomers.
    J L Dul, S Aviel, J Melnick and Y Argon
    J Immunol October 1, 1996, 157 (7) 2969-2975;
  • You have accessRestricted access
    Differential binding avidities of human IgM for staphylococcal protein A derive from specific germ-line VH3 gene usage.
    M Hakoda, N Kamatani, S Hayashimoto-Kurumada, G J Silverman, H Yamanaka, C Terai and S Kashiwazaki
    J Immunol October 1, 1996, 157 (7) 2976-2981;
  • You have accessRestricted access
    Staphylococcal protein A simultaneously interacts with framework region 1, complementarity-determining region 2, and framework region 3 on human VH3-encoded Igs.
    K N Potter, Y Li and J D Capra
    J Immunol October 1, 1996, 157 (7) 2982-2988;
  • You have accessRestricted access
    Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen.
    M Rheinnecker, C Hardt, L L Ilag, P Kufer, R Gruber, A Hoess, A Lupas, C Rottenberger, A Plückthun and P Pack
    J Immunol October 1, 1996, 157 (7) 2989-2997;
  • You have accessRestricted access
    Human dendritic cells phagocytose and process Borrelia burgdorferi.
    L Filgueira, F O Nestlé, M Rittig, H I Joller and P Groscurth
    J Immunol October 1, 1996, 157 (7) 2998-3005;
  • You have accessRestricted access
    IL-12 gene therapy protects mice in lethal Klebsiella pneumonia.
    M J Greenberger, S L Kunkel, R M Strieter, N W Lukacs, J Bramson, J Gauldie, F L Graham, M Hitt, J M Danforth and T J Standiford
    J Immunol October 1, 1996, 157 (7) 3006-3012;
  • You have accessRestricted access
    Structure-function analysis of Leishmania lipophosphoglycan. Distinct domains that mediate binding and inhibition of endothelial cell function.
    J L Ho, H K Kim, P M Sass, S He, J Geng, H Xu, B Zhu, S J Turco and S K Lo
    J Immunol October 1, 1996, 157 (7) 3013-3020;
  • You have accessRestricted access
    A highly variable region in members of the streptococcal M protein family binds the human complement regulator C4BP.
    E Johnsson, A Thern, B Dahlbäck, L O Hedén, M Wikström and G Lindahl
    J Immunol October 1, 1996, 157 (7) 3021-3029;
  • You have accessRestricted access
    Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes.
    A Mazzocchi, W J Storkus, C Traversari, P Tarsini, M J Maeurer, L Rivoltini, C Vegetti, F Belli, A Anichini, G Parmiani and C Castelli
    J Immunol October 1, 1996, 157 (7) 3030-3038;
  • You have accessRestricted access
    Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
    M Oukka, J C Manuguerra, N Livaditis, S Tourdot, N Riche, I Vergnon, P Cordopatis and K Kosmatopoulos
    J Immunol October 1, 1996, 157 (7) 3039-3045;
  • You have accessRestricted access
    Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni.
    J A Pedras-Vasconcelos and E J Pearce
    J Immunol October 1, 1996, 157 (7) 3046-3053;
  • You have accessRestricted access
    NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection.
    T P Salazar-Mather, R Ishikawa and C A Biron
    J Immunol October 1, 1996, 157 (7) 3054-3064;
  • You have accessRestricted access
    Protection against lethal influenza virus encephalitis by intranasally primed CD8+ memory T cells.
    P G Stevenson, S Hawke and C R Bangham
    J Immunol October 1, 1996, 157 (7) 3065-3073;
  • You have accessRestricted access
    Exhaustion of CTL memory and recrudescence of viremia in lymphocytic choriomeningitis virus-infected MHC class II-deficient mice and B cell-deficient mice.
    A R Thomsen, J Johansen, O Marker and J P Christensen
    J Immunol October 1, 1996, 157 (7) 3074-3080;
  • You have accessRestricted access
    Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    J J Westendorf and D F Jelinek
    J Immunol October 1, 1996, 157 (7) 3081-3088;
  • You have accessRestricted access
    Tumor necrosis factor-alpha modulates the expression of its p60 receptor and several cytokines in rat tracheal epithelial cells.
    T Bader and P Nettesheim
    J Immunol October 1, 1996, 157 (7) 3089-3096;
  • You have accessRestricted access
    Characterization of murine lung interstitial macrophages in comparison with alveolar macrophages in vitro.
    G Franke-Ullmann, C Pförtner, P Walter, C Steinmüller, M L Lohmann-Matthes and L Kobzik
    J Immunol October 1, 1996, 157 (7) 3097-3104;
  • You have accessRestricted access
    Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids.
    M J Hébert, T Takano, H Holthöfer and H R Brady
    J Immunol October 1, 1996, 157 (7) 3105-3115;
  • You have accessRestricted access
    Diminished production of prostaglandin E2 by monocytes of newborns is due to altered fatty acid membrane content and reduced cyclooxygenase activity.
    F J Murphy and D J Reen
    J Immunol October 1, 1996, 157 (7) 3116-3121;
  • You have accessRestricted access
    Bradykinin stimulates alveolar macrophages to release neutrophil, monocyte, and eosinophil chemotactic activity.
    E Sato, S Koyama, H Nomura, K Kubo and M Sekiguchi
    J Immunol October 1, 1996, 157 (7) 3122-3129;
  • You have accessRestricted access
    Regulation of sialoadhesin expression on rat macrophages. Induction by glucocorticoids and enhancement by IFN-beta, IFN-gamma, IL-4, and lipopolysaccharide.
    T K van den Berg, I van Die, C R de Lavalette, E A Döpp, L D Smit, P H van der Meide, F J Tilders, P R Crocker and C D Dijkstra
    J Immunol October 1, 1996, 157 (7) 3130-3138;
  • You have accessRestricted access
    Zinc enhances lipopolysaccharide-induced monokine secretion by alteration of fluidity state of lipopolysaccharide.
    N Wellinghausen, A B Schromm, U Seydel, K Brandenburg, J Luhm, H Kirchner and L Rink
    J Immunol October 1, 1996, 157 (7) 3139-3145;
  • You have accessRestricted access
    Molecular analysis of stimulatory anti-thyrotropin receptor antibodies (TSAbs) involved in Graves' disease. Isolation and reconstruction of antibody genes, and production of monoclonal TSAbs.
    T Akamizu, F Matsuda, J Okuda, H Li, H Kanda, T Watanabe, T Honjo and T Mori
    J Immunol October 1, 1996, 157 (7) 3148-3152;
  • You have accessRestricted access
    Reduced susceptibility to collagen-induced arthritis in mice deficient in intercellular adhesion molecule-1.
    D C Bullard, L A Hurley, I Lorenzo, L M Sly, A L Beaudet and N D Staite
    J Immunol October 1, 1996, 157 (7) 3153-3158;
  • You have accessRestricted access
    Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    G S Early, W Zhao and C M Burns
    J Immunol October 1, 1996, 157 (7) 3159-3164;
  • You have accessRestricted access
    In vivo properties of an IgG3-IL-2 fusion protein. A general strategy for immune potentiation.
    E T Harvill, J M Fleming and S L Morrison
    J Immunol October 1, 1996, 157 (7) 3165-3170;
  • You have accessRestricted access
    Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3).
    O Memar, B Christensen, S Rajaraman, R Goldblum, S K Tyring, M M Brysk, D J McCormick, H el-Zaim, J L Fan and B S Prabhakar
    J Immunol October 1, 1996, 157 (7) 3171-3177;
  • You have accessRestricted access
    Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice.
    L Mori, S Iselin, G De Libero and W Lesslauer
    J Immunol October 1, 1996, 157 (7) 3178-3182;
  • You have accessRestricted access
    Persistent clonal expansions of peripheral blood CD4+ lymphocytes in chronic inflammatory bowel disease.
    C S Probert, A Chott, J R Turner, L J Saubermann, A C Stevens, K Bodinaku, C O Elson, S P Balk and R S Blumberg
    J Immunol October 1, 1996, 157 (7) 3183-3191;
  • You have accessRestricted access
    B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
    J S Rosenberg, M Oshima and M Z Atassi
    J Immunol October 1, 1996, 157 (7) 3192-3199;
  • You have accessRestricted access
    Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane.
    M Satoh, K J Hamilton, A K Ajmani, X Dong, J Wang, Y S Kanwar and W H Reeves
    J Immunol October 1, 1996, 157 (7) 3200-3206;
Back to top
PreviousNext
PreviousNext

This Issue

The Journal of Immunology
Vol. 157, Issue 7
1 Oct 1996
  • Table of Contents
  • Table of Contents (PDF)
Sign up for alerts

Jump to

  • CUTTING EDGE
  • ARTICLES
  • Highlights
  • Most Cited
  • Most Read
Loading
Immunodominant AH1 Antigen-Deficient Necroptotic, but Not Apoptotic, Murine Cancer Cells Induce Antitumor Protection
Osteoclasts Derive Predominantly from Bone Marrow–Resident CX3CR1+ Precursor Cells in Homeostasis, whereas Circulating CX3CR1+ Cells Contribute to Osteoclast Development during Fracture Repair
Intracellular IL-1 Receptor Antagonist Isoform 1 Released from Keratinocytes upon Cell Death Acts as an Inhibitor for the Alarmin IL-1α
Polysaccharide Capsules Equip the Human Symbiont Bacteroides thetaiotaomicron to Modulate Immune Responses to a Dominant Antigen in the Intestine
Natural and Induced Tolerogenic Dendritic Cells
Cutting Edge: IL-6–Driven Immune Dysregulation Is Strictly Dependent on IL-6R α-Chain Expression

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • Public Access
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606